FDA Inspection 1016317 — Eurofins BioPharma Product Testing Sweden AB
The FDA completed an inspection of Eurofins BioPharma Product Testing Sweden AB on May 12, 2017 in Uppsala. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Uppsala (Sweden)